https://www.newswise.com/articles/new-hormonal-agent-may-slow-progression-of-early-stage-prostate-cancer-during-active-surveillance
For men with early-stage prostate cancer being managed by active surveillance, adding the hormonal agent apalutamide may lower the rate of positive biopsies dur
Create an account or login to join the discussion